NCT07441798

Brief Summary

Stroke and traumatic brain injury frequently result in persistent upper and lower limb motor impairment. While conventional rehabilitation improves outcomes, patient adherence and training intensity remain limiting factors. Immersive virtual reality (VR)-based therapy may enhance neuroplasticity by delivering high-intensity, task-oriented motor practice with enriched sensory feedback. This randomized controlled trial evaluates the efficacy and safety of the 6Degrees MyMove interactive VR system compared to passive VR exposure in individuals undergoing subacute inpatient rehabilitation after stroke or traumatic brain injury. Sixty participants will be randomized 1:1 to receive either interactive VR-based motor training or passive VR viewing, in addition to standard rehabilitation care, three times weekly for eight weeks. The primary objective is to determine whether interactive VR leads to greater improvement in motor function compared to passive VR. Secondary outcomes include dexterity, gait speed, functional independence, psychological status, adherence, usability, and safety.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
31mo left

Started Mar 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Mar 2026Dec 2028

First Submitted

Initial submission to the registry

February 24, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 2, 2026

Completed
16 days until next milestone

Study Start

First participant enrolled

March 18, 2026

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2028

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

March 2, 2026

Status Verified

February 1, 2026

Enrollment Period

2.2 years

First QC Date

February 24, 2026

Last Update Submit

February 24, 2026

Conditions

Keywords

Virtual Reality TherapyUpper Limb RehabilitationStroke RehabilitationFugl-Meyer AssessmentNeurorehabilitationWearable Motion Sensors

Outcome Measures

Primary Outcomes (1)

  • Fugl-Meyer Assessment - Upper Extremity (FMA-UE)

    A standardized, stroke-specific measure of upper-limb motor impairment assessing movement, coordination, and reflex activity. Scores range from 0 to 66, with higher scores indicating better motor function.

    Week 8 (Immediate post-intervention), 1 month follow-up, and 3 months follow-up

Secondary Outcomes (4)

  • Finger Tapping Test

    Week 8 (Immediate post-intervention), 1 month follow-up, and 3 months follow-up

  • Box and Blocks Test (BBT)

    Week 8 (Immediate post-intervention), 1 month follow-up, and 3 months follow-up

  • 10-Meter Walk Test (10MWT)

    Immediate post-intervention (8 weeks)

  • Five Times Sit-to-Stand Test (5xSTS)

    Immediate post-intervention (8 weeks)

Other Outcomes (2)

  • EQ-5D-5L

    Immediate post-intervention (8 weeks)

  • System Usability Scale (SUS)

    Immediate post-intervention (8 weeks)

Study Arms (2)

MyMove/VR system

EXPERIMENTAL

The treatment system consists of two lightweight MyMove bands and Virtual-Reality (VR) gear. Proprietary software and content allow tracking of performance in real-time, with feedback to both the patient and treating - personnel.

Device: MyMove/VR system

Passive VR

ACTIVE COMPARATOR

Passive VR involves the use of a head-mounted display to present immersive audiovisual content (e.g., movies, 360-degree videos, or virtual environments) without requiring active engagement, task performance, or interaction with the virtual environment.

Device: Passive VR

Interventions

During each session, participants will engage in goal-directed motor exercises within an immersive VR environment delivered through a head-mounted display. Tasks are designed to promote range of motion, coordination, motor control, and functional movement. The system provides real-time visual and auditory feedback and adapts task difficulty based on individual performance and motor capacity.

MyMove/VR system

Participants in the control arm will receive immersive virtual reality exposure using a head-mounted display. The content will include movies, 360-degree videos, or virtual environments designed to provide audiovisual immersion without requiring active motor engagement or task performance.

Passive VR

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Time since neurological event: At least 2 weeks post-stroke or post-head injury.
  • Motor impairment: Upper extremities: Presence of hemiparesis without complete paralysis. Participants receiving rehabilitation focused on functional transfer to the contralateral hand using compensatory or adaptive motor learning strategies will also be eligible. Lower extremities: Presence of partial voluntary movement sufficient to allow participation in rehabilitation training.
  • Cognitive ability: Sufficient cognitive capacity to understand instructions and engage with VR-based training, as determined by the principal investigator and/or treating physician.
  • Medical stability: Medically stable condition allowing participation in the training.
  • Informed consent: Ability to provide written informed consent personally or via a legal guardian.
  • Final eligibility will be determined by the principal investigator/ treating physician.

You may not qualify if:

  • Severe cognitive or language impairment: Cognitive deficits or language comprehension impairments that prevent safe and meaningful participation.
  • Neurological deficits interfering with VR: Severe hemispatial neglect or visual field deficits that interfere with VR use. Moderate neglect may be permitted at the investigator's discretion.
  • Medical contraindications:
  • Uncontrolled epilepsy
  • Severe vestibular or vertigo disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Reuth Rehabilitation Hospital - Tel Aviv

Tel Aviv, 6772830, Israel

Location

Related Publications (3)

  • Curiel RC, Nakamura T, Kuzuoka H, Kanaya T, Prahm C, Matsumoto K. Virtual Reality Self Co-Embodiment: An Alternative to Mirror Therapy for Post-Stroke Upper Limb Rehabilitation. IEEE Trans Vis Comput Graph. 2024 May;30(5):2390-2399. doi: 10.1109/TVCG.2024.3372035. Epub 2024 Apr 19.

    PMID: 38437102BACKGROUND
  • Ciullo G, Bozzetti F, Ziccarelli S, Fogassi L, Errante A. Neurophysiological mechanisms underlying action observation treatment for upper limb stroke rehabilitation: A mini-review. Neurosci Biobehav Rev. 2026 Jan;180:106484. doi: 10.1016/j.neubiorev.2025.106484. Epub 2025 Nov 19.

    PMID: 41270979BACKGROUND
  • Bargeri S, Scalea S, Agosta F, Banfi G, Corbetta D, Filippi M, Sarasso E, Turolla A, Castellini G, Gianola S. Effectiveness and safety of virtual reality rehabilitation after stroke: an overview of systematic reviews. EClinicalMedicine. 2023 Sep 14;64:102220. doi: 10.1016/j.eclinm.2023.102220. eCollection 2023 Oct.

    PMID: 37745019BACKGROUND

MeSH Terms

Conditions

Brain Injuries, TraumaticStroke

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesCerebrovascular DisordersVascular DiseasesCardiovascular Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 24, 2026

First Posted

March 2, 2026

Study Start

March 18, 2026

Primary Completion (Estimated)

May 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

March 2, 2026

Record last verified: 2026-02

Locations